Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development

被引:0
作者
Jee Eun Rhee
Mi Yeong Shin
Choong Mo Kim
Hye Young Kee
Jae Keun Chung
Sang-Kee Min
Seong-Joon Kim
Dai-Ho Jang
Sung Soon Kim
Byeong-Sun Choi
机构
[1] National Institute of Health,Division of AIDS, Center for Immunology and Pathology
[2] Korea Centers for Disease Control and Prevention,Division of Microbiology
[3] Jeollanam-Do Institute of Health and Environment,Department of Health Research
[4] Gwangju Institute of Health and Environment,Division of Epidemiology
[5] Busan Institute of Health and Environment,undefined
来源
Virology Journal | / 7卷
关键词
Cervical Cancer; Invasive Cervical Cancer; Korean Woman; Precancerous Cervical Lesion; South Korean Woman;
D O I
暂无
中图分类号
学科分类号
摘要
We investigated the prevalence of human papillomavirus (HPV) infection and the distribution of high-risk HPV genotypes among 2,308 high-risk Korean women to predict how much the current prophylactic HPV vaccines might affect the prevention of cervical cancer in Korea. HPV DNA was detected in 939 women (40.7%) but only one-third of women were positive for HPV-16 and/or HPV-18, the genotypes used for developing the HPV vaccines. Thus, the development of area-specific HPV vaccines based on dominant HPV genotypes in our country is needed for preventing HPV infection and the development of premalignant lesions in the cervix of Korean women.
引用
收藏
相关论文
共 138 条
  • [1] Bosch FX(2002)The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 244-265
  • [2] Lorincz A(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19
  • [3] Munoz N(2005)Nationwide cancer incidence in Korea 1999-2001; First result using the national cancer incidence database Cancer Res Treat 37 325-331
  • [4] Meijer CJ(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527
  • [5] Shah KV(2002)Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong J Med Virol 68 273-277
  • [6] Walboomers JM(2008)Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis J Microbiol Biotechnol 18 788-794
  • [7] Jacobs MV(2007)Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials Lancet 369 1861-1868
  • [8] Manos MM(2007)Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a Phase III double-blind, randomized controlled trial Lancet 369 2161-2170
  • [9] Bosch FX(2007)Human papillomavirus and HPV vaccines: a review Bull World Health Organ 85 719-726
  • [10] Kummer JA(2009)High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines J Med Virol 81 545-551